Menu
Back to Journals » Breast Cancer: Targets and Therapy » Volume 17
ISSN: 1179-1314
- View all (594)
- Volume 17, 2025 (47)
- Volume 16, 2024 (76)
- Volume 15, 2023 (79)
- Volume 14, 2022 (41)
- Volume 13, 2021 (58)
- Volume 12, 2020 (27)
- Volume 11, 2019 (32)
- Volume 10, 2018 (24)
- Volume 9, 2017 (64)
- Volume 8, 2016 (26)
- Volume 7, 2015 (36)
- Volume 6, 2014 (20)
- Volume 5, 2013 (13)
- Volume 4, 2012 (22)
- Volume 3, 2011 (16)
- Volume 2, 2010 (9)
- Volume 1, 2009 (4)
Archive: Volume 17, 2025
Peripheral TNF-α and CD8+/CD28+ T Lymphocytes as Alternatives for PD-L1 Prediction in Breast Cancer Tumor Microenvironment: Stratified by Neoadjuvant Therapy
Wu J, Ou X, Yuan K, Shi F, Zhou Q, Lyu S, Li Y, Zhao Y, Cao Y, Sun J, Song Q
Breast Cancer: Targets and Therapy 2025, 17:627-637
Published Date: 19 July 2025
A Machine-Learning Model for the Prediction of Triple-Negative Breast Cancer Based on Multiparameter MRI
Cai Y, Li Y, Wang W, Zhou Y, Wang J, Zhang L, Lu H
Breast Cancer: Targets and Therapy 2025, 17:611-625
Published Date: 15 July 2025
Simultaneous Implant and Dermal Flap Technique for Breast Reconstruction After Skin-Sparing Total Mastectomy for Breast Carcinoma
Agdoğan Ö, Gürdal özkan S
Breast Cancer: Targets and Therapy 2025, 17:599-610
Published Date: 14 July 2025
Exploring the Mechanism of Lianqiao Jinbei Decoction Inhibiting HER2-Positive Breast Cancer Based on Network Pharmacology and Experimental Verification
Li D, Liu X, Fan H, Dong J, Wei L, Guo N, Wang Z, Du Z, Liu J, Zhao X, Tian X, Han C, Yao X
Breast Cancer: Targets and Therapy 2025, 17:583-598
Published Date: 14 July 2025
Heterogeneity Assessment of Breast Cancer Tumor Microenvironment: Multiparametric Quantitative Analysis with DCE-MRI and Discovery of Radiomics Biomarkers
Ma W, Yang L, Zhang Y, Gao Y, Jie H, Huang C
Breast Cancer: Targets and Therapy 2025, 17:573-581
Published Date: 8 July 2025
Male Breast Cancer: Evaluating the Current Landscape of Diagnosis and Treatment
Ter-Zakarian A, Agelidis A, Jaloudi M
Breast Cancer: Targets and Therapy 2025, 17:567-572
Published Date: 5 July 2025
Advancements in Dalpiciclib for the Treatment of Breast Cancer Patients: A Review
Chen Z, Xie P, Chen Q, Ouyang J
Breast Cancer: Targets and Therapy 2025, 17:557-565
Published Date: 30 June 2025
Continuous Anlotinib Combined with Oral Vinorelbine has Shown Anti-Tumor Efficiency in Refractory HER2 Negative Advanced Breast Cancer
Huang JY, Zhang Y, Du CW
Breast Cancer: Targets and Therapy 2025, 17:545-555
Published Date: 28 June 2025
Current Strategies to Reducing Interval Breast Cancers: A Systematic Review
Goh RSJ, Chong B, Yeo S, Neo SY, Ng QX, Goh SSN
Breast Cancer: Targets and Therapy 2025, 17:531-544
Published Date: 27 June 2025
Triple-Negative Breast Cancer on the Rise: Breakthroughs and Beyond
Agelidis A, Ter-Zakarian A, Jaloudi M
Breast Cancer: Targets and Therapy 2025, 17:523-529
Published Date: 26 June 2025
Research Progress of PROTAC-Degraded CDKs in the Treatment of Breast Cancer
Zhao K, Zhang J, Yang Z, Wang R, Shi Y, Ji Y, Zhang S, Liu M
Breast Cancer: Targets and Therapy 2025, 17:511-521
Published Date: 13 June 2025
A Prognostic Nutritional Index-Based Nomogram to Predict Breast Cancer Metastasis: A Retrospective Cohort Validation
Chen Z, Gao H, Cheng M, Song C
Breast Cancer: Targets and Therapy 2025, 17:497-510
Published Date: 10 June 2025
Radiation-Based Multi-Modal Therapy Combining with Immunotherapy to Develop a Vaccine-Like Effective Treatment for Triple-Negative Breast Cancer
Dai M, Tian Z, Xu F, Yao B, Liang H, Li D, Wang J, Rong J, Liu T, Tang H, Lu H, Zhang W
Breast Cancer: Targets and Therapy 2025, 17:483-496
Published Date: 10 June 2025
ALKBH5 Promotes Breast Cancer Stemness Through Regulating Wnt/β-Catenin Signaling
Wang K, Wang K
Breast Cancer: Targets and Therapy 2025, 17:471-482
Published Date: 6 June 2025
CD151 Promotes Cancer Progression in Triple-Negative Breast Cancer by Inducing EMT through the MAPK Signaling Pathway
Lv H, Zhang B, Weng X, Li Y, Deng C, Wang R, Shi L, Yin Y
Breast Cancer: Targets and Therapy 2025, 17:455-470
Published Date: 28 May 2025
Promising Response to Neoadjuvant Chemotherapy Plus Immunotherapy in Metaplastic Breast Carcinoma
Tan Q, Li N, Wang Y, Du T, Liang G, Zhao Z, Tang J, Wu H
Breast Cancer: Targets and Therapy 2025, 17:447-454
Published Date: 23 May 2025
Barriers to Early Breast Cancer Diagnosis in Sudanese Women Before the War
Elamin HES, Elamin HES, Abd El-Raheem GOH, Noma M
Breast Cancer: Targets and Therapy 2025, 17:433-445
Published Date: 20 May 2025
Advances in Targeted Therapy for Brain Metastases in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer: A Focus on ADCs and TKIs
Rao B, Huo P, Lu J, Huang W
Breast Cancer: Targets and Therapy 2025, 17:423-432
Published Date: 19 May 2025
Naples Prognostic Score (NPS) as a Novel Prognostic Score for Stage III Breast Cancer Patients: A Real-World Retrospective Study
Miao Y, Yang R, Zhang B, Yang J, Yao L, Wang W, Liu X, Guo X, Jia H
Breast Cancer: Targets and Therapy 2025, 17:403-421
Published Date: 12 May 2025
Exploring the Potential of Chaihu-Danggui Tang in Breast Cancer Treatment Based on Network Pharmacology, Molecular Docking, and Experimental Validation
Liu Y, Zhang J, Lai Y, Wu C, Liu D, Liang R, Chen G, Jiang X
Breast Cancer: Targets and Therapy 2025, 17:385-401
Published Date: 10 May 2025
A Comparative Analysis of Mobile versus Stationary Mammography Units: Performance and Outcomes in a Breast Cancer Screening Program
Tari DU, De Lucia DR, Santonastaso R, Santarsiere M, Blasotti A
Breast Cancer: Targets and Therapy 2025, 17:373-383
Published Date: 7 May 2025
Immune and Metabolic Reprogramming Induced by Paclitaxel, Capecitabine and Eribulin in Breast Cancer: Insights into Therapeutic Targets
Hsiao HH, Patel R, Kalinski P, Takabe K, Ernstoff MS, Rosario SR, Gandhi S
Breast Cancer: Targets and Therapy 2025, 17:359-372
Published Date: 29 April 2025
Unveiling the Landscape of PD-L1 Expression and Tumor-Infiltrating Lymphocyte Subtypes in Advanced Triple-Negative Breast Cancer in Brazil
Dos Santos ALS, Da Silva JL, De Albuquerque LZ, Neto ALA, Da Silva CF, Cerva LAM, Small IA, Rodrigues FR, De Macedo FC, Marcelino CP, Batista PDM, Rego MADC, Borba MACSM, De Melo AC
Breast Cancer: Targets and Therapy 2025, 17:349-358
Published Date: 15 April 2025
Current Status of Breast Cancer Immunotherapy and Prognosis-Related Markers
Xu Y, Zhang B, Wu H, Wu Y
Breast Cancer: Targets and Therapy 2025, 17:339-348
Published Date: 15 April 2025
HGH1 Promotes Breast Cancer Progression Through the PI3K/AKT/NF-κB Signaling Pathway: Potential Role for Prognosis and Targeted Therapy
Hu W, Si D, Liu C, Tie D, Xu D, Li N
Breast Cancer: Targets and Therapy 2025, 17:325-337
Published Date: 14 April 2025
The Comprehensive Analysis of Weighted Gene Co-Expression Network Analysis and Machine Learning Revealed Diagnostic Biomarkers for Breast Implant Illness Complicated with Breast Cancer
Huang Z, Wang H, Pang H, Zeng M, Zhang G, Liu F
Breast Cancer: Targets and Therapy 2025, 17:305-324
Published Date: 10 April 2025
Exploration of Traditional Chinese Medicine Comprehensive Treatment of Triple Negative Breast Cancer Based on Molecular Pathological Mechanism
Zhu M, Liu Y, Wen Z, Tan H, Li S, Yu X, Luo H, Li D, Wang J, Qin F
Breast Cancer: Targets and Therapy 2025, 17:289-304
Published Date: 10 April 2025
Shear Wave Elastography: A Non-Invasive Approach for Assessing TGF-β1/MAPK Signaling Molecules and EMT in Breast Cancer
Huang S, Wang B, Jiang Y, Li S, Li J, Wang Z
Breast Cancer: Targets and Therapy 2025, 17:275-287
Published Date: 26 March 2025
Diagnosis, Prognosis, and Treatment of Triple-Negative Breast Cancer: A Review
Jie H, Ma W, Huang C
Breast Cancer: Targets and Therapy 2025, 17:265-274
Published Date: 17 March 2025
Genetic Alterations in HER2-Positive and Equivocal Breast Cancer by Immunohistochemistry
Tsai YF, Hsu CY, Chiu YN, Huang CC, Chou SH, Lin YS, Chao TC, Liu CY, Chiu JH, Tseng LM
Breast Cancer: Targets and Therapy 2025, 17:253-263
Published Date: 12 March 2025
Ultrasound-Guided Percutaneous Microwave Coagulation Studies on VX2 Rabbit Models for Breast Cancer Treatment and Ultrasound Imaging Assessment
Gao Q, Huang H, Shi JJ, Wang L, Li WM
Breast Cancer: Targets and Therapy 2025, 17:241-252
Published Date: 25 February 2025
Telomere Maintenance-Related Genes are Essential for Prognosis in Breast Cancer
Huang W, Wang W, Dong TZ
Breast Cancer: Targets and Therapy 2025, 17:225-239
Published Date: 24 February 2025
Tumor Microenvironment Modulation by Tumor-Associated Macrophages: Implications for Neoadjuvant Chemotherapy Response in Breast Cancer
Oner G, Praet MM, Stoop H, Devi GR, Canturk NZ, Altintas S, Van Berckelaer C, Berneman Z, Tjalma W, Koljenovic S, van Dam PA
Breast Cancer: Targets and Therapy 2025, 17:211-224
Published Date: 21 February 2025
Real-World Analysis of the Efficacy and Adverse Events of T-DM1 in Chinese Patients With HER2-Positive Breast Cancer
Gu H, Zhu T, Ding J, Yang Z, Qi S, Guo G
Breast Cancer: Targets and Therapy 2025, 17:201-210
Published Date: 21 February 2025
Radiomics Integration of Mammography and DCE-MRI for Predicting Molecular Subtypes in Breast Cancer Patients
Yang X, Li J, Sun H, Chen J, Xie J, Peng Y, Shang T, Pan T
Breast Cancer: Targets and Therapy 2025, 17:187-200
Published Date: 18 February 2025
Quality of Life in Breast Cancer Patients in Saudi Arabia: A Systematic Review
Aljadani FF, Nughays RO, Alharbi GE, Almazroy EA, Elyas SK, Danish HE, Alanazi RT, Aldrees BA, Jadkarim GA, Mikwar Z
Breast Cancer: Targets and Therapy 2025, 17:171-186
Published Date: 18 February 2025
Lactate Dehydrogenase-A-Forming LDH5 Promotes Breast Cancer Progression
Fang T, Hu L, Chen T, Li F, Yang L, Liang B, Wang W, Zeng F
Breast Cancer: Targets and Therapy 2025, 17:157-170
Published Date: 12 February 2025
The Prediction Model of High-Frequency Ultrasound Combined with Artificial Intelligence-Assisted Scoring System Improved the Diagnosis of Sclerosing Adenosis and Early Breast Cancer
Ma B, Wu G, Zhu H, Liu Y, Hu W, Zhao J, Liu Y, Liu Q
Breast Cancer: Targets and Therapy 2025, 17:145-155
Published Date: 7 February 2025
Programmed Cell Death Ligand 1 (PD-L1) and Major Histocompatibility Complex Class I (MHC Class I) Expression Patterns and Their Pathologic Associations in Triple-Negative Breast Cancer
Kaewkedsri P, Intarawichian P, Jessadapattarakul S, Kunprom W, Koonmee S, Thanee M, Somintara O, Wongbuddha A, Chadbunchachai P, Nawapun S, Aphivatanasiri C
Breast Cancer: Targets and Therapy 2025, 17:123-143
Published Date: 6 February 2025
Analysis of Mammography BI-RADS Distribution and Follow-up Ultrasound Assessment: A Single-Center Study
Kankaya B, Buyukasik S, Altundal YE, Topcu FS, Rahmanbakhsh P, Etemad A, Kapan S, Alis H
Breast Cancer: Targets and Therapy 2025, 17:115-122
Published Date: 6 February 2025
Predicting Axillary Lymph Node Metastasis in Young Onset Breast Cancer: A Clinical-Radiomics Nomogram Based on DCE-MRI
Dong X, Meng J, Xing J, Jia S, Li X, Wu S
Breast Cancer: Targets and Therapy 2025, 17:103-113
Published Date: 27 January 2025
Adipokines in Breast Cancer: Decoding Genetic and Proteomic Mechanisms Underlying Migration, Invasion, and Proliferation
Ließem A, Leimer U, Germann GK, Köllensperger E
Breast Cancer: Targets and Therapy 2025, 17:79-102
Published Date: 25 January 2025
Non-Luminal Disease Score for Everolimus in Patients with Hormone Receptor‑positive and Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Multicenter and Retrospective Study
Tan Y, Jiang H, Tian X, Ma F, Wang J, Zhang P, Xu B, Fan Y, Zhao W
Breast Cancer: Targets and Therapy 2025, 17:67-78
Published Date: 24 January 2025
Update on Pulmonary Toxicity Induced by New Breast Cancer Treatments
Belluzzi L, Martinelli G, Medici B, Farina A, Martinelli E, Canino F, Caggia F, Molinaro A, Barbolini M, Tamburrano F, Moscetti L, Piacentini F, Dominici M, Omarini C
Breast Cancer: Targets and Therapy 2025, 17:53-66
Published Date: 21 January 2025
From Pioneering Discoveries to Innovative Therapies: A Journey Through the History and Advancements of Nanoparticles in Breast Cancer Treatment
Basingab FS, Alshahrani OA, Alansari IH, Almarghalani NA, Alshelali NH, Alsaiary AH, Alharbi N, Zaher KA
Breast Cancer: Targets and Therapy 2025, 17:27-51
Published Date: 21 January 2025
Functional Analysis and Experimental Validation of the Prognostic and Immune Effects of the Oncogenic Protein CDC45 in Breast Cancer
Zhang JN, Li LW, Cao MQ, Liu X, Yi ZL, Liu SS, Liu H
Breast Cancer: Targets and Therapy 2025, 17:11-25
Published Date: 9 January 2025
Optimizing Xenograft Models for Breast Cancer: A Comparative Analysis of Cell-Derived and Patient-Derived Implantation Techniques in Pre-Clinical Research
Khairani AF, Harmonia S, Chou Y, Alfarafisa NM, Ramadhanti J
Breast Cancer: Targets and Therapy 2025, 17:1-10
Published Date: 9 January 2025